Innoviva (INVA, Financial) has recently caught the attention of HC Wainwright & Co., as the investment firm has initiated coverage of the stock with a "Buy" rating. This decision was announced on July 14, 2025, by analyst Raghuram Selvaraju, who is closely monitoring the promising developments within Innoviva.
In conjunction with the new coverage, HC Wainwright has set a price target for Innoviva at $40.00 USD. This target signifies a positive outlook for the company's future market performance, pointing to potential growth opportunities that investors might find appealing.
The initiation of coverage by HC Wainwright, without a prior rating or price target for Innoviva, marks a new phase of market interest and could potentially influence investor perceptions positively. As market participants take note of this coverage, it will be interesting to observe how this impacts Innoviva's stock (INVA, Financial) in the coming periods.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 2 analysts, the average target price for Innoviva Inc (INVA, Financial) is $40.50 with a high estimate of $55.00 and a low estimate of $26.00. The average target implies an upside of 115.77% from the current price of $18.77. More detailed estimate data can be found on the Innoviva Inc (INVA) Forecast page.
Based on the consensus recommendation from 2 brokerage firms, Innoviva Inc's (INVA, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Innoviva Inc (INVA, Financial) in one year is $23.57, suggesting a upside of 25.57% from the current price of $18.77. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Innoviva Inc (INVA) Summary page.
